(Q36774177)

16 August 2017

1 reference

title

Zileuton: clinical implications of 5-Lipoxygenase inhibition in severe airway disease (English)

1 reference

16 August 2017

W Berger

1

1 reference

PubMed ID

17394438

16 August 2017

M T M De Chandt

series ordinal

2

1 reference

PubMed ID

17394438

16 August 2017

C B Cairns

series ordinal

3

1 reference

16 August 2017

1 April 2007

1 reference

International Journal of Clinical Practice

16 August 2017

1 reference

16 August 2017

61

1 reference

16 August 2017

4

1 reference

16 August 2017

663-676

1 reference

Increased glucocorticoid receptor beta in airway cells of glucocorticoid-insensitive asthma.

16 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2007.01320.X

Effect of oral prednisone on airway inflammatory mediators in atopic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2007.01320.X

Environmental tobacco smoke and adult asthma. The impact of changing exposure status on health outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2007.01320.X

Anti-inflammatory effects of zileuton in a subpopulation of allergic asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2007.01320.X

The Pivotal Role of 5-Lipoxygenase Products in the Reaction of Aspirin-sensitive Asthmatics to Aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2007.01320.X

10.1111/J.1742-1241.2007.01320.X

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference

PubMed ID

17394438